TY - JOUR AU - Mohammad, Zaahirah AU - Ahmad, Norliza AU - Baharom, Anisah PY - 2022 DA - 2022/6/27 TI -基于理论的教育干预和WhatsApp随访对马来西亚产后妇女Papanicolaou涂片摄取的影响:随机对照试验乔- Uhealth Mhealth JMIR SP - e32089六世- 10 - 6千瓦子宫宫颈肿瘤KW -巴氏试验KW -心理学理论KW -自我效能KW -社会媒体KW -健康知识KW -态度KW -实践KW -马来西亚AB -背景:尽管自由子宫颈的可用性和可访问性(Pap)涂片作为宫颈癌筛查工具,子宫颈抹片检查的吸收在马来西亚没有改变在过去的15年。以前的研究表明，宫颈抹片检查的高吸收量可降低宫颈癌患者的死亡率。巴氏涂片的低吸收率是多因素的，通过使用移动技术可以最大限度地减少这个问题。然而，大多数干预研究侧重于个体因素，而其他重要方面，如移动技术，特别是WhatsApp，尚未进行调查。目的:本研究旨在确定基于理论的教育干预和WhatsApp随访(巴氏涂片摄取[PSU]干预)在改善马来西亚森美兰州雪兰市产后妇女PSU方面的效果。方法:对Seremban地区的产后妇女进行双臂、平行、单盲群随机对照试验。12家诊所被随机分配到干预组和对照组。在基线时，两组都接受了一份自我管理的问卷。干预组接受研究人员提供的标准护理和PSU干预。 This 2-stage intervention module was developed based on Social Cognitive Theory, where the first stage was conducted face-to-face and the second stage included a WhatsApp follow-up. The control group received standard care. Participants were observed immediately and at 4, 8, and 12 weeks after the intervention. The primary endpoint was PSU, whereas the secondary endpoints were knowledge, attitude, and self-efficacy scores for Pap smear screening self-assessed using a Google Forms questionnaire. A generalized mixed model was used to determine the effectiveness of the intervention. All data were analyzed using IBM SPSS (version 25), and P value of .05 was considered statistically significant. Results: We analyzed 401 women, of whom 76 (response rate: 325/401, 81%) had withdrawn because of the COVID-19 pandemic, with a total of 162 respondents in the intervention group and 163 respondents in the control group. The proportion of Pap smears at the 12-week follow-up was 67.9% (110/162) in the intervention group versus 39.8% (65/163) in the control group (P<.001). Significant differences between the intervention and control groups were found for Pap smear use (F4,1178; P<.001), knowledge scores (F4,1172=14.946; P<.001), attitude scores (F4,1172=24.417; P<.001), and self-efficacy scores (F1,1172=10.432; P<.001). Conclusions: This study demonstrated that the PSU intervention is effective in increasing the uptake of Pap smear among postnatal women in Seremban district, Malaysia. This intervention module can be tested in other populations of women. Trial Registration: Thai Clinical Trials Registry TCTR20200205001; https://www.thaiclinicaltrials.org/show/TCTR20200205001 SN - 2291-5222 UR - https://mhealth.www.mybigtv.com/2022/6/e32089 UR - https://doi.org/10.2196/32089 UR - http://www.ncbi.nlm.nih.gov/pubmed/35759319 DO - 10.2196/32089 ID - info:doi/10.2196/32089 ER -